Skip to main content
. 2023 Mar 21;31(7):1904–1919. doi: 10.1016/j.ymthe.2023.03.017

Figure 1.

Figure 1

Schematic of selected RAS targeted therapeutics

Current RAS targeted therapeutics that are in pre-clinical and clinical development are grouped by mechanism of action. Only those that specifically target RAS are listed. See Table 1 for more details on in vitro, in vivo, and clinical studies. Figure created with Biorender.com.